These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1987991)

  • 21. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
    Geisel J; Oette K; Burrichter H
    Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
    Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC
    Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    Mölgaard J; von Schenck H; Olsson AG
    Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.
    Couture P; Brun LD; Szots F; Lelièvre M; Gaudet D; Després JP; Simard J; Lupien PJ; Gagné C
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1007-12. PubMed ID: 9633944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels.
    Cassader M; Ruiu G; Gambino R; Alemanno N; Veglia F; Pagano G
    Atherosclerosis; 1993 Feb; 99(1):47-53. PubMed ID: 8461059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One year experience in the treatment of familial hypercholesterolaemia with simvastatin.
    Quiney J; Watts GF; Kerr-Muir M; Slavin B; Lewis B
    Postgrad Med J; 1992 Jul; 68(801):575-80. PubMed ID: 1437957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R; Bovet P; Brunner HR; Bercher L
    Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study Group.
    Itoh T; Matsumoto M; Hougaku H; Handa N; Tsubakihara Y; Yamada Y; Imaizumi M; Hoshi M; Shimazu Y; Hori M; Kawamori R; Ueda N; Fusamoto H; Kamada T
    Clin Ther; 1997; 19(3):487-97. PubMed ID: 9220213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin in the treatment of hypercholesterolemia in elderly patients.
    Antonicelli R; Onorato G; Pagelli P; Pierazzoli L; Paciaroni E
    Clin Ther; 1990; 12(2):165-71. PubMed ID: 2354486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.
    Tobert JA
    Circulation; 1987 Sep; 76(3):534-8. PubMed ID: 3113763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant increase of high-density lipoprotein2-cholesterol under prolonged simvastatin treatment.
    Neuman MP; Neuman HR; Neuman J
    Atherosclerosis; 1991 Dec; 91 Suppl():S11-9. PubMed ID: 1789812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia.
    Tomlinson B; Mak TW; Tsui JY; Woo J; Shek CC; Critchley JA; Masarei JR
    Am J Cardiol; 1995 Jul; 76(2):136A-139A. PubMed ID: 7604789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of specific mutations at the LDL-receptor gene locus on the response to simvastatin therapy in Afrikaner patients with heterozygous familial hypercholesterolaemia.
    Jeenah M; September W; Graadt van Roggen F; de Villiers W; Seftel H; Marais D
    Atherosclerosis; 1993 Jan; 98(1):51-8. PubMed ID: 8457250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
    Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
    Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.
    Berger GM; Marais AD; Seftel HC; Baker SG; Mendelsohn D; Welsh NH; Joffe BI
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):219-27. PubMed ID: 2487533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.